U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07651917) titled 'Effect of Supplemental Oxygen Therapy on Neurocognitive Performance in Healthy Highlanders' on June 03.
Brief Summary: Exposure to high altitudes, defined as locations above 2500 m, has been shown to cause cognitive alternations due to reduced blood oxygenation (SpO2). However, it remains to be determined whether cognitive changes are present in highlanders living at moderate altitudes (2500 m) and whether cognitive alterations are reversible with supplemental oxygen therapy (SOT).
Study Start Date: June 18
Study Type: INTERVENTIONAL
Condition:
Neurocognition
Intervention:
DRUG: Supplemental oxygen therapy
5 L/min supplementa...